Metabometrix
Metabometrix Ltd is a pioneering company in the field of metabonomics, specializing in developing and applying advanced technologies for analyzing metabolic responses in biological systems. The company is built on the expertise of the world's leading metabonomics research team at Imperial College, London, and collaborates with major pharmaceutical and healthcare industry players. Its mission is to revolutionize drug discovery, disease diagnosis, and personalized medicine through innovative metabonomics solutions.
Industries
Nr. of Employees
small (1-50)
Products
Blood-based metabolic-profile test for coronary artery disease (developmental)
A diagnostic approach using metabolic profiling of standard blood preparations and multivariate analysis to detect and assess severity of coronary artery disease from small blood samples.
Blood-based metabolic-profile test for coronary artery disease (developmental)
A diagnostic approach using metabolic profiling of standard blood preparations and multivariate analysis to detect and assess severity of coronary artery disease from small blood samples.
Services
Contract analysis of biofluid or tissue samples to generate metabolic profiles, perform multivariate analysis and deliver interpreted reports for research or industry clients.
Early-stage screening of compounds in preclinical models using metabolic profiling to detect toxicity signatures and rank candidates.
Identification of metabolic biomarkers and development support for clinical assays with options for validation and partnership for commercialisation.
Development and provision of processed spectral databases, automated processing routines and informatics tools for NMR and MS data management.
Courses and invited lectures on NMR-based metabonomics and multivariate data analysis for practitioners and industry audiences.
Contract analysis of biofluid or tissue samples to generate metabolic profiles, perform multivariate analysis and deliver interpreted reports for research or industry clients.
Early-stage screening of compounds in preclinical models using metabolic profiling to detect toxicity signatures and rank candidates.
Identification of metabolic biomarkers and development support for clinical assays with options for validation and partnership for commercialisation.
Development and provision of processed spectral databases, automated processing routines and informatics tools for NMR and MS data management.
Courses and invited lectures on NMR-based metabonomics and multivariate data analysis for practitioners and industry audiences.
Expertise Areas
- Metabonomics / metabolomics
- NMR-based metabolic profiling
- Mass spectrometry–based metabolomics (LC–MS, Q‑TOF)
- Chemometrics and multivariate data analysis
Key Technologies
- Proton and high-resolution NMR spectroscopy (including MAS)
- Liquid chromatography–mass spectrometry (LC–MS)
- Quadrupole time-of-flight (Q‑TOF) mass spectrometry
- Flow-injection mass spectrometry
News & Updates
The article 'Contemporary issues in toxicology - The role of metabonomics in toxicology and its evaluation by the COMET project' by Professor John C. Lindon is one of the most cited papers in the field.
UK researchers at Imperial College London have developed a metabonomics-based blood test for heart disease that is rapid, inexpensive, and minimally invasive.
A review article in Nature Reviews Drug Discovery discussing the applications of metabonomics in drug toxicity and gene function studies.
Professor John C. Lindon's article recognized as one of the most cited papers in the field.
The article 'Contemporary issues in toxicology - The role of metabonomics in toxicology and its evaluation by the COMET project' by Professor John C. Lindon is one of the most cited papers in the field.
UK researchers at Imperial College London have developed a metabonomics-based blood test for heart disease that is rapid, inexpensive, and minimally invasive.
A review article in Nature Reviews Drug Discovery discussing the applications of metabonomics in drug toxicity and gene function studies.
Professor John C. Lindon's article recognized as one of the most cited papers in the field.